We are conducting research into medical treatments with great potential for the next generation.

Inquiry about Seeds Collection

Target Discovery Using Affinity Resins

Information updated: July 31, 2023

Seeds Information

keyword

Target Discovery, Affinity Resins, AquaFirmus

Field

Chemical Biology

Overview

Our proprietary AqurFirmus is a methacrylate resin derived from PEG, so it is chemically stable and can be used to immobilize biologically active substances such as compounds and perform other chemical modifications even under organic solvent conditions. In addition, because it is hydrophilic, it has little non-specific protein adsorption and produces little noise that can hinder target protein identification. Furthermore, since the improved AqurFirmus is polymerized using long PEG, it is possible to identify even large target protein complexes.

What's new?

"AqurFirmus affinity resin" is a technology discovered exclusively by the researchers, and has the potential to become a new tool in drug discovery research.

What are its advantages over other studies?

This resin is chemically stable and has the following advantages:

  • Organic compounds can be immobilized on the resin under organic solvent conditions.
  • Hydrophilicity reduces the adsorption of non-specific proteins that can hinder identification
  • The improved AqurFirmus uses long PEG for polymerization, making it possible to identify even large target protein complexes.
  • The improved AquaFirmus has a variety of PEG lengths, eliminating the need to optimize the linker length between the ligand and the solid support.

What problem does it help solve?

Applications in the search for targets of unknown drugs under development or target protein complexes

Possibility of other applications and developments

Protein separation and purification by utilizing the chemical stability and low non-specific protein adsorption by introducing photocleavable linkers, etc.

Related Patents

PCA/JP2013/236265, "Novel solid phase carrier"

Reference Chart

01.png

 

02.png

Researcher Information

full name Akito Tanaka
Affiliation School of Pharmacy Medicinal Chemistry (Chemical Biology)
Specialization Chemical Biology
Collaborative Researcher Miyuki Mabuchi
Related links

What do you expect from collaboration with companies?

  • Identification of target proteins of biologically active substances with unknown targets, and further development of compound synthesis
  • Use in other applications

Contact for this research

兵庫医科大学 大学事務部 研究推進課
E-mail: chizai@hyo-med.ac.jp
Tel: 0798-45-6488